ISSN 2147-9720 | E-ISSN 2148-4279
Case Report
A report of three cases with lupus myelitis
1 Department of Rheumatology, Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Japan; Department of Internal Medicine, Hiroshima City Hiroshima Citizens Hospital  
2 Department of Internal Medicine, Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Japan  
3 Department of General Medicine, Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Japan  
4 Department of Neurology, Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Japan  
5 Department of Clinical Immunology and Rheumatology, Hiroshima University Hospital, Hiroshima, Japan  
Eur J Rheumatol 2017; 4: 148-150
DOI: 10.5152/eurjrheum.2017.160099
This article was viewed 403 times, downloaded 139 times

Key Words: Lupus myelitis, systemic lupus erythematosus, transverse myelitis, lupus anti-coagulant, anti-cardiolipin antibody, anti-cardiolipin beta-2 glicoprotein-1 antibody
Abstract

Lupus myelitis (LM) is a rare but serious complication of systemic lupus erythematosus (SLE). In 2009, Birnbaum et al. suggested that LM could be classified into two subtypes, namely gray and white matter myelitis, based on neurological examination findings. Here we describe three cases of this disorder, one with signs of white matter dysfunction and two with signs of gray matter dysfunction. We discuss the potential role of autoantibodies in the development of LM.

Key Words
Authors
All
Author’s Corner
Survey
AVES | Copyright © 2017 Medical Research and Education Association | Latest Update: 09.06.2017